What does CUSIP 04611X101 represent in this 13F holders report?

CUSIP 04611X101 is the security identifier for 04611X101 - INTRA CELLULAR THERAPIES INC - COM used to aggregate holder disclosures.

How many institutions held 04611X101 - INTRA CELLULAR THERAPIES INC - COM in Q3 2017?

No institutional holders were reported for 04611X101 - INTRA CELLULAR THERAPIES INC - COM in Q3 2017; review adjacent reporting periods for trend context.

INTRA CELLULAR THERAPIES INC - COM

CUSIP: 04611X101

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -85,000
Total reported value: $0
Number of holders: 0
Value change: -$1,056,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 04611X101?
CUSIP 04611X101 identifies 04611X101 - INTRA CELLULAR THERAPIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2017

Recent filing periods for CUSIP 04611X101:

Q3 2017 Q2 2017

INTRA CELLULAR THERAPIES INC - COM

Q3 2017 13F Holders as of 30 Sep 2017

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of INTRA CELLULAR THERAPIES INC - COM as of Q3 2017.